Order Article Reprints

Zuccaro V, Petazzoni G, Mileto I, Corbella M, Asperges E, Sacchi P, Rattotti S, Varettoni M, Defrancesco I, Cambieri P, et al. Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study. Microorganisms. 2023; 11(5):1305. https://doi.org/10.3390/microorganisms11051305

Zuccaro, Valentina, Greta Petazzoni, Irene Mileto, Marta Corbella, Erika Asperges, Paolo Sacchi, Sara Rattotti, Marzia Varettoni, Irene Defrancesco, Patrizia Cambieri, and et al. 2023. "Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study" Microorganisms 11, no. 5: 1305. https://doi.org/10.3390/microorganisms11051305

Zuccaro, V., Petazzoni, G., Mileto, I., Corbella, M., Asperges, E., Sacchi, P., Rattotti, S., Varettoni, M., Defrancesco, I., Cambieri, P., Baldanti, F., Arcaini, L., & Bruno, R. (2023). Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study. Microorganisms, 11(5), 1305. https://doi.org/10.3390/microorganisms11051305